← 홈

ADC

13개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-14 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 13개
ADCBBiologicActinium PharmaceuticalsreleasePhase 2

Daunorubicin (Daunorubicin)

Acute Leukemia of Ambiguous Lineage; B Acute Lymphoblastic Leukemia · Leukemia

#Leukemia#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 95%임상시험 72상태 RECRUITING
ADCBiologicAlliance for Clinical Trials in…releasePhase 3

Daunorubicin Hydrochloride (Daunorubicin Hydrochloride)

B Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 95%임상시험 69상태 RECRUITING
ADCBiologicAlliance for Clinical Trials in…Phase 3

Thioguanine (Thioguanine)

B Acute Lymphoblastic Leukemia · Leukemia

#Leukemia#ADC#Phase3#인기#항체약물접합체+4
임상시험 58상태 RECRUITING
ADCBiologicPfizerthatPhase 3

Inotuzumab ozogamicin (Inotuzumab ozogamicin)

Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia · Precursor Cell Lymphoblastic Leukemia-Ly

#PrecursorCellLymphoblasticLeukem#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 93.3%임상시험 52상태 RECRUITING
ADCBiologicmedac GmbHPhase 2

Asparaginase Erwinia chrysanthemi (Asparaginase Erwinia chrysanthemi)

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative; T Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 18%임상시험 42상태 RECRUITING
ADCBiologicstaleBellicum PharmaceuticalsPhase 2

Rimiducid (Rimiducid)

Acute Lymphoblastic Leukemia; Leukemia, Acute Myeloid (AML), Child · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 31상태 RECRUITING
ADCBiologicstaleAmgenPhase 3

calaspargase pegol (calaspargase pegol)

B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma · NK-Cell Lymphoma

#NK-CellLymphoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 28상태 RECRUITING
ADCBiologicPfizerPhase 2

ALLR3 (ALLR3)

ACUTE LYMPHOBLASTIC LEUKEMIA · ACUTE LYMPHOBLASTIC LEUKEMIA

#ACUTELYMPHOBLASTICLEUKEMIA#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 3상태 RECRUITING
ADCBiologicAstraZenecaPhase 2

AZD4512 monotherapy (AZD4512 monotherapy)

B-cell Acute Lymphoblastic Leukemia (B-ALL) · B-cell Acute Lymphoblastic Leukemia (B-A

#B-cellAcuteLymphoblasticLeukemia#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleAmgenPhase 2

Blinatumomab and Inotuzumab Ozogamicin (Blinatumomab and Inotuzumab Ozogamicin)

Acute Lymphoblastic Leukemia; Immunotherapy · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleInstitut Paoli-CalmettesPhase 1

INA03 administration (INA03 administration)

Acute Lymphoblastic Leukemia Recurrent; Acute Lymphoblastic Leukemia, in Relapse · Acute Lymphoblastic Leukemia Recurrent

#AcuteLymphoblasticLeukemiaRecurr#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 ACTIVE
ADCBiologicstaleM.D. Anderson Cancer CenterPhase 1

STI-6129 (Part 1, Part 1 (STI-6129))

Refractory T Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia (AML) · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 DISCONTINUED
ADCBiologicstaleM.D. Anderson Cancer CenterPhase 1

STI-6129 (Part 2, Part 2 (STI-6129))

Refractory T Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia (AML) · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 DISCONTINUED